Novo, Lilly shares fall as Trump touts ‘much lower’ Ozempic price
Mehmet Oz, head of the Centers for Medicare and Medicaid Services, said talks over the price of weight-loss drugs are still ongoing.
Health Care & Insurance
Articles
Dr. Richard Feldman: Biden dropped ball on menthol, so Trump should push on
Menthol cigarettes have been aggressively marketed to African Americans, creating a significant disparity in use.
CDC recommends coronavirus vaccine with new caveat. Here’s what to know.
The Centers for Disease Control and Prevention on Monday said it had officially recommended updated COVID vaccines, creating a new system to get a shot that’s slightly more complicated than in previous years.
Drug made from marijuana reduced back pain in large study
The 800-patient study by a German drugmaker is the latest evidence of the therapeutic properties of cannabis, which remains illegal under U.S. federal law even as most states have made it available for medical or recreational use.
Government shutdown draws closer as congressional leaders head to the White House
White House aides, ahead of the meeting, made it clear the Republican administration had no intention to negotiate.
What new tariffs mean for pharmaceuticals, patented drugs
President Donald Trump’s announcement that his administration will impose a 100 percent tariff on patented pharmaceutical products sparked confusion Friday, as government officials, drug companies and trade groups sought clarity on how the levy would be applied.
Indiana interim courts committee concludes without recommendations
After meeting for just over three cumulative hours this year, the interim courts committee came to a close Tuesday without making any recommendations on its assigned topic: medical debt.
CVS Health subsidiary Omnicare files for bankruptcy protection
The filing comes two months after the long-term care business was ordered to pay $949 million when a federal court found it liable for filing fraudulent claims for some prescription drugs.
Pfizer amps up push into obesity treatments with $4.9B deal for Metsera
Demand for obesity treatments has soared recently, due to unprecedented weight loss provided by regular injections of market leaders Wegovy from Novo Nordisk and Zepbound from Indianapolis-based Eli Lilly and Co.
Weight-loss drugs can cut future health costs. The fight is over who pays now.
Evidence from clinical trials shows that GLP-1s have benefits beyond weight loss, preventing related chronic conditions and ultimately blunting health-plan costs. But the savings might take decades, experts say.
Medicaid work requirements delayed until 2027 following federal action
Other parts of Indiana’s HIP 3.0 proposal are still under consideration, including an expansion on provider taxes, cost-sharing requirements and wellness incentives.
New bill seeks to restore millions in Medicaid funding to Indiana hospitals
Hospital leaders who spoke with Inside INdiana Business emphasized the bill wouldn’t increase funding, it would give hospitals access to funding that’s already been allocated.
Health insurance premiums poised to spike over drug costs, tariff threats
In explaining the rising prices, insurers and employers point to two recent factors: the tariffs on pharmaceutical imports and the high cost of new obesity treatments.
Appeals court allows Trump administration to block Medicaid funds to Planned Parenthood
Planned Parenthood said Thursday’s ruling means that more than 1.1 million patients can’t use their Medicaid insurance at its health centers.
Trump’s plan for drug advertising crackdown faces many hurdles
President Donald Trump signed a memo Tuesday that directs the FDA and other agencies to step up enforcement against ubiquitous prescription drug ads on TV, websites and social media.
Lilly rival Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs
The restructuring, which would eliminate 11% of the company’s workforce, aimed to reduce organizational complexity and speed up decision-making as the company faces a more competitive market for obesity drugs.
Trump plans hefty tax on imported drugs, risking higher prices, shortages
The threat comes as Trump also pressures drugmakers to lower prices of pharmaceuticals in the United States.
Small Columbus health insurer tries to take on the giants
SIHO Insurance Services is tackling the gargantuan challenge of growth in the employer-based benefits market in Indianapolis and across the state.
Legislators take closer look at medical debt protections
Indiana ranks 11th among the states in terms of the percentage of population with medical debt in collections, one survey shows.
FDA OKs updated COVID shots with limits for some children, adults
The revamped vaccines target a newer version of the continuously evolving virus and are set to begin shipping soon.